Join
Live feed
·
INSIDERFilingvia Quantisnow
Axsome Therapeutics Inc. logo

Director Coleman Mark exercised 12,485 shares at a strike of $4.95, increasing direct ownership by 23% to 65,890 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AXSM (Axsome Therapeutics Inc.) and more on Quantisnow.